Lexeo Therapeutics (LXEO) Stock Chart & Stock Price History $4.51 -0.10 (-2.17%) Closing price 04:00 PM EasternExtended Trading$4.58 +0.07 (+1.44%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexeo Therapeutics Stock Price Performance The Lexeo Therapeutics (LXEO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 74.35%, with a year-to-date return of -31.46%. In the past month, the stock has increased 67.66%, reflecting recent market activity. As of the latest close, Lexeo Therapeutics traded at $4.61 with a market cap of $153.04 million and volume of 826,200 shares. Receive LXEO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+16.24%1 Month Performance+67.66%3 Month Performance+69.55%Year-To-Date Performance-31.46%1 Year Performance-74.35% LXEO Stock Chart for Wednesday, June, 11, 2025 LXEO Chart by TradingView Lexeo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$4.61$4.51-2.17%$4.75$4.26824,809 shs$149.72 million06/10/2025$4.38$4.61+5.25%$4.63$4.27826,200 shs$153.04 million06/09/2025$3.88$4.38+12.89%$4.40$3.85870,717 shs$145.40 million06/06/2025$3.27$3.88+18.65%$4.21$3.301.93 million shs$128.80 million06/05/2025$3.10$3.27+5.48%$3.33$2.90705,236 shs$108.55 million06/04/2025$2.82$3.10+9.93%$3.18$2.80647,666 shs$102.91 million06/03/2025$2.72$2.82+3.68%$2.97$2.72672,260 shs$93.62 million06/02/2025$2.76$2.72-1.45%$2.88$2.72354,466 shs$90.30 million05/30/2025$2.87$2.76-3.83%$2.89$2.67371,002 shs$91.62 million05/29/2025$2.74$2.87+4.74%$2.91$2.66447,432 shs$95.28 million Get the Latest News and Ratings for LXEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$2.70$2.74+1.48%$2.89$2.51564,287 shs$90.96 million05/27/2025$2.82$2.70-4.26%$3.08$2.542.05 million shs$89.63 million05/26/2025$2.82$2.82$3.06$2.81480,722 shs$93.62 million05/23/2025$3.08$2.82-8.44%$3.06$2.81480,722 shs$93.62 million05/22/2025$3.06$3.08+0.65%$3.17$2.90323,258 shs$102.25 million05/21/2025$3.53$3.06-13.31%$3.50$2.88899,897 shs$101.58 million05/20/2025$3.29$3.53+7.29%$3.59$3.11620,590 shs$117.19 million05/19/2025$3.24$3.29+1.54%$3.31$2.98718,415 shs$109.22 million05/16/2025$2.70$3.24+20.00%$3.47$2.661.74 million shs$107.56 million05/15/2025$2.69$2.70+0.37%$2.81$2.43801,709 shs$89.63 million05/14/2025$2.83$2.69-4.95%$2.86$2.53957,160 shs$89.30 million05/13/2025$2.63$2.83+7.60%$2.98$2.55871,814 shs$93.95 million05/12/2025$2.69$2.63-2.23%$3.11$2.531.02 million shs$87.31 million Related Companies Rezolute Stock Chart Arcturus Therapeutics Stock Chart ADC Therapeutics Stock Chart Rapport Therapeutics Stock Chart Organogenesis Stock Chart SNDL Stock Chart Inventiva Stock Chart Phathom Pharmaceuticals Stock Chart Aura Biosciences Stock Chart Entrada Therapeutics Stock Chart Receive LXEO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexeo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LXEO) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
